{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:25:40Z","timestamp":1715988340049},"reference-count":133,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","mayoclinicproceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.mayocp.2016.04.009","type":"journal-article","created":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T10:46:23Z","timestamp":1470048383000},"page":"1133-1146","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Management of Hormone Deprivation Symptoms After Cancer"],"prefix":"10.1016","volume":"91","author":[{"given":"Stephanie S.","family":"Faubion","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles L.","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn J.","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.mayocp.2016.04.009_bib1","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.2105\/AJPH.2005.066936","article-title":"Longitudinal analysis of the association between vasomotor symptoms and race\/ethnicity across the menopausal transition: study of women's health across the nation","volume":"96","author":"Gold","year":"2006","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.seminoncol.2013.09.002","article-title":"Sexual and reproductive health in cancer survivors","volume":"40","author":"Goldfarb","year":"2013","journal-title":"Semin Oncol"},{"issue":"suppl 12B","key":"10.1016\/j.mayocp.2016.04.009_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2005.09.046","article-title":"Hot flashes: behavioral treatments, mechanisms, and relation to sleep","volume":"118","author":"Freedman","year":"2005","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1001\/jamainternmed.2014.8063","article-title":"Duration of menopausal vasomotor symptoms over the menopause transition","volume":"175","author":"Avis","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/GME.0000000000000196","article-title":"Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort","volume":"21","author":"Freeman","year":"2014","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.mayocp.2016.04.009_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.mayocp.2016.04.009_bib7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/jnci\/dji071","article-title":"Menopausal hormone therapy after breast cancer: the Stockholm randomized trial","volume":"97","author":"von Schoultz","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1056\/NEJMoa0807684","article-title":"Breast cancer after use of estrogen plus progestin in postmenopausal women","volume":"360","author":"Chlebowski","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.mayocp.2016.04.009_bib9","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/GME.0000000000000546","article-title":"Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society","volume":"22","year":"2015","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/GME.0000000000000301","article-title":"Caffeine and menopausal symptoms: what is the association?","volume":"22","author":"Faubion","year":"2015","journal-title":"Menopause"},{"issue":"13","key":"10.1016\/j.mayocp.2016.04.009_bib11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinternmed.2010.162","article-title":"An intensive behavioral weight loss intervention and hot flushes in women","volume":"170","author":"Huang","year":"2010","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/gme.0b013e31824f606e","article-title":"Effects of a dietary intervention and weight change on vasomotor symptoms in the Women's Health Initiative","volume":"19","author":"Kroenke","year":"2012","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/GME.0000000000000274","article-title":"Behavioral weight loss for the management of menopausal hot flashes: a pilot study","volume":"22","author":"Thurston","year":"2015","journal-title":"Menopause"},{"issue":"13","key":"10.1016\/j.mayocp.2016.04.009_bib14","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1200\/JCO.2011.36.8597","article-title":"Effect of postdiagnosis weight change on hot flash status among early-stage breast cancer survivors","volume":"30","author":"Caan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0002-9378(11)91425-2","article-title":"Behavioral treatment of menopausal hot flushes: evaluation by ambulatory monitoring","volume":"167","author":"Freedman","year":"1992","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3109\/01674829609025684","article-title":"The effects of relaxation response training on menopausal symptoms","volume":"17","author":"Irvin","year":"1996","journal-title":"J\u00a0Psychosom Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0005-7916(97)00030-X","article-title":"Treatment of menopausal symptoms with applied relaxation: a pilot study","volume":"28","author":"Wijma","year":"1997","journal-title":"J\u00a0Behav Ther Exp Psychiatry"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11606-012-2202-6","article-title":"Paced respiration for vasomotor and other menopausal symptoms: a randomized, controlled trial","volume":"28","author":"Carpenter","year":"2013","journal-title":"J\u00a0Gen Intern Med"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/GME.0b013e31826934b6","article-title":"Paced breathing compared with usual breathing for hot flashes","volume":"20","author":"Sood","year":"2013","journal-title":"Menopause"},{"issue":"7","key":"10.1016\/j.mayocp.2016.04.009_bib20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/gme.0b013e31823fe835","article-title":"Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial","volume":"19","author":"Ayers","year":"2012","journal-title":"Menopause"},{"key":"10.1016\/j.mayocp.2016.04.009_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1471-2407-11-44","article-title":"A\u00a0randomised controlled trial of a cognitive behavioural intervention for women who have menopausal symptoms following breast cancer treatment (MENOS 1): trial protocol","volume":"11","author":"Mann","year":"2011","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/00029157.2004.10401473","article-title":"Can hypnosis reduce hot flashes in breast cancer survivors? a literature review","volume":"47","author":"Elkins","year":"2004","journal-title":"Am J Clin Hypn"},{"issue":"5","key":"10.1016\/j.mayocp.2016.04.009_bib23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/pon.1096","article-title":"Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors","volume":"16","author":"Elkins","year":"2007","journal-title":"Psychooncology"},{"issue":"31","key":"10.1016\/j.mayocp.2016.04.009_bib24","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1200\/JCO.2008.16.6389","article-title":"Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors","volume":"26","author":"Elkins","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/gme.0b013e31826ce3ed","article-title":"Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial","volume":"20","author":"Elkins","year":"2013","journal-title":"Menopause"},{"issue":"S33","key":"10.1016\/j.mayocp.2016.04.009_bib26","article-title":"Pilot study of a biobehavioral treatment for hot flashes","volume":"45","author":"Barton","year":"2013","journal-title":"Ann Behav Med"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib27","doi-asserted-by":"crossref","first-page":"e003138","DOI":"10.1136\/bmjopen-2013-003138","article-title":"Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study","volume":"3","author":"Maclaughlan David","year":"2013","journal-title":"BMJ Open"},{"issue":"31","key":"10.1016\/j.mayocp.2016.04.009_bib28","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1200\/JCO.2015.60.9412","article-title":"Electroacupuncture versus gabapentin for hot flashes among breast cancer survivors: a randomized placebo-controlled trial","volume":"33","author":"Mao","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"22","key":"10.1016\/j.mayocp.2016.04.009_bib29","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1002\/cncr.29630","article-title":"Systematic review of acupuncture to control hot flashes in cancer patients","volume":"121","author":"Garcia","year":"2015","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/GME.0000000000000374","article-title":"North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes","volume":"22","author":"Park","year":"2015","journal-title":"Menopause"},{"issue":"18","key":"10.1016\/j.mayocp.2016.04.009_bib31","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1200\/JCO.2005.05.4296","article-title":"Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1","volume":"24","author":"Pockaj","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.mayocp.2016.04.009_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-137-10-200211190-00009","article-title":"Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials","volume":"137","author":"Kronenberg","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mayocp.2016.04.009_bib33","first-page":"CD001395","article-title":"Phytoestrogens for menopausal vasomotor symptoms","volume":"12","author":"Lethaby","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.mayocp.2016.04.009_bib34","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1200\/JCO.2000.18.5.1068","article-title":"Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group trial","volume":"18","author":"Quella","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/gme.0b013e318223b021","article-title":"A\u00a0phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7","volume":"19","author":"Pruthi","year":"2012","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1200\/JCO.1998.16.2.495","article-title":"Prospective evaluation of vitamin E for hot flashes in breast cancer survivors","volume":"16","author":"Barton","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/gme.0b013e31818c91ca","article-title":"Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis","volume":"16","author":"Bardia","year":"2009","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib38","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","article-title":"Transdermal clonidine for ameliorating tamoxifen-induced hot flashes","volume":"12","author":"Goldberg","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.mayocp.2016.04.009_bib39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","article-title":"Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study","volume":"132","author":"Pandya","year":"2000","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2016.04.009_bib40","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1200\/JCO.1998.16.7.2377","article-title":"Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors","volume":"16","author":"Loprinzi","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1008382706068","article-title":"A\u00a0pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors","volume":"11","author":"Stearns","year":"2000","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib42","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1075-122X.2006.00218.x","article-title":"Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen","volume":"12","author":"Kimmick","year":"2006","journal-title":"Breast J"},{"issue":"9247","key":"10.1016\/j.mayocp.2016.04.009_bib43","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","article-title":"Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial","volume":"356","author":"Loprinzi","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib44","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.20.6.1578","article-title":"Phase III evaluation of fluoxetine for treatment of hot flashes","volume":"20","author":"Loprinzi","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.mayocp.2016.04.009_bib45","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1001\/jama.289.21.2827","article-title":"Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial","volume":"289","author":"Stearns","year":"2003","journal-title":"JAMA"},{"issue":"28","key":"10.1016\/j.mayocp.2016.04.009_bib46","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1200\/JCO.2005.10.081","article-title":"Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial","volume":"23","author":"Stearns","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib47","doi-asserted-by":"crossref","first-page":"172.e1","DOI":"10.1016\/j.ajog.2008.09.877","article-title":"A\u00a0double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause","volume":"200","author":"Archer","year":"2009","journal-title":"Am J Obstet Gynecol"},{"issue":"20","key":"10.1016\/j.mayocp.2016.04.009_bib48","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1200\/JCO.2009.26.6379","article-title":"Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9","volume":"28","author":"Barton","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib49","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2012.03.001","article-title":"Effect of escitalopram on hot flash interference: a randomized, controlled trial","volume":"97","author":"Carpenter","year":"2012","journal-title":"Fertil Steril"},{"issue":"8","key":"10.1016\/j.mayocp.2016.04.009_bib50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/gme.0b013e31820ccae9","article-title":"Escitalopram treatment of menopausal hot flashes","volume":"18","author":"Freedman","year":"2011","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.2010.2016","article-title":"Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial","volume":"305","author":"Freeman","year":"2011","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.mayocp.2016.04.009_bib52","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/ebm1406","article-title":"Escitalopram reduced hot flashes in non-depressed perimenopausal and postmenopausal women","volume":"16","author":"Soares","year":"2011","journal-title":"Evid Based Med"},{"issue":"10","key":"10.1016\/j.mayocp.2016.04.009_bib53","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/GME.0b013e3182a66aa7","article-title":"Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials","volume":"20","author":"Simon","year":"2013","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1200\/JCO.2012.44.6625","article-title":"Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters","volume":"31","author":"Brauch","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.5306\/wjco.v5.i4.693","article-title":"Caring for the breast cancer survivor's health and well-being","volume":"5","author":"Casey","year":"2014","journal-title":"World J Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib56","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/gme.0b013e3180dca175","article-title":"Gabapentin for the treatment of menopausal hot flashes: a randomized controlled trial","volume":"15","author":"Butt","year":"2008","journal-title":"Menopause"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib57","first-page":"337","article-title":"Gabapentin's effects on hot flashes in postmenopausal women: a randomized controlled trial","volume":"101","author":"Guttuso","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"9488","key":"10.1016\/j.mayocp.2016.04.009_bib58","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0140-6736(05)67215-7","article-title":"Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial","volume":"366","author":"Pandya","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.AOG.0000222383.43913.ed","article-title":"Gabapentin, estrogen, and placebo for treating hot flushes: a randomized controlled trial","volume":"108","author":"Reddy","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JCO.2009.24.5647","article-title":"Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1","volume":"28","author":"Loprinzi","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"35","key":"10.1016\/j.mayocp.2016.04.009_bib61","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1200\/JCO.2010.29.9230","article-title":"Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors","volume":"28","author":"Bordeleau","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"3, pt 1","key":"10.1016\/j.mayocp.2016.04.009_bib62","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.gme.0000243574.01441.3e","article-title":"Oxybutynin for refractory hot flashes in cancer patients","volume":"14","author":"Sexton","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.mayocp.2016.04.009_bib63","unstructured":"Laguardia KD, inventor. Treatment of hot flashes using muscarinic receptor antagonists such as oxybutynin [patent report].\u00a02007. http:\/\/www.google.com\/patents\/WO2007143486A2?cl=en. Accessed April 29, 2016."},{"issue":"1-2","key":"10.1016\/j.mayocp.2016.04.009_bib64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000435834","article-title":"The therapeutic effect of stellate ganglion block on facial nerve palsy in patients with type 2 diabetes mellitus","volume":"74","author":"Luo","year":"2015","journal-title":"Eur Neurol"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib65","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/anae.12774","article-title":"Analgesic efficacy of pre-operative stellate ganglion block on postoperative pain relief: a randomised controlled trial","volume":"69","author":"Kumar","year":"2014","journal-title":"Anaesthesia"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib66","first-page":"E379","article-title":"Effects of ultrasound-guided stellate ganglion block on acute pain after arthroscopic shoulder surgery","volume":"18","author":"Choi","year":"2015","journal-title":"Pain Physician"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib67","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.mehy.2009.01.009","article-title":"A\u00a0unifying theory linking the prolonged efficacy of the stellate ganglion block for the treatment of chronic regional pain syndrome (CRPS), hot flashes, and posttraumatic stress disorder (PTSD)","volume":"72","author":"Lipov","year":"2009","journal-title":"Med Hypotheses"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib68","first-page":"e320","article-title":"Safety and patient acceptability of stellate ganglion blockade as a treatment adjunct for combat-related post-traumatic stress disorder: a quality assurance initiative","volume":"7","author":"McLean","year":"2015","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib69","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.mehy.2007.01.082","article-title":"Stellate ganglion block may relieve hot flashes by interrupting the sympathetic nervous system","volume":"69","author":"Lipov","year":"2007","journal-title":"Med Hypotheses"},{"issue":"8","key":"10.1016\/j.mayocp.2016.04.009_bib70","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1089\/jwh.2005.14.737","article-title":"Stellate ganglion blockade provides relief from menopausal hot flashes: a case report series","volume":"14","author":"Lipov","year":"2005","journal-title":"J\u00a0Womens Health (Larchmt)"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib71","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1470-2045(08)70131-1","article-title":"Effects of stellate-ganglion block on hot flushes and night awakenings in survivors of breast cancer: a pilot study","volume":"9","author":"Lipov","year":"2008","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib72","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/annonc\/mdr478","article-title":"Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up","volume":"23","author":"Haest","year":"2012","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2016.04.009_bib73","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00520-010-0907-9","article-title":"Pilot evaluation of a stellate ganglion block for the treatment of hot flashes","volume":"19","author":"Pachman","year":"2011","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib74","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/13697137.2012.709889","article-title":"Stellate-ganglion block as a treatment for severe postmenopausal flushing","volume":"16","author":"van Gastel","year":"2013","journal-title":"Climacteric"},{"issue":"8","key":"10.1016\/j.mayocp.2016.04.009_bib75","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/GME.0000000000000194","article-title":"Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women","volume":"21","author":"Walega","year":"2014","journal-title":"Menopause"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib76","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/pme.12331","article-title":"Management of hot flushes in breast cancer survivors: comparison between stellate ganglion block and pregabalin","volume":"15","author":"Othman","year":"2014","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib77","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199408113310602","article-title":"Megestrol acetate for the prevention of hot flashes","volume":"331","author":"Loprinzi","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib78","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1789::AID-CNCR27>3.0.CO;2-#","article-title":"Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes","volume":"82","author":"Quella","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.mayocp.2016.04.009_bib79","first-page":"CD004310","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","volume":"3","author":"Ruiz Garcia","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.mayocp.2016.04.009_bib80","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.2006.10.6179","article-title":"Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626","volume":"26","author":"Goodwin","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib81","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/annonc\/mdf151","article-title":"Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study","volume":"13","author":"Bertelli","year":"2002","journal-title":"Ann Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib82","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1200\/JCO.2005.04.7324","article-title":"Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7","volume":"24","author":"Loprinzi","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib83","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0885-3924(02)00525-0","article-title":"Depomedroxyprogesterone acetate for hot flashes","volume":"24","author":"Barton","year":"2002","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib84","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/13697137.2012.660613","article-title":"Hormone therapy, dementia, and cognition: the Women's Health Initiative 10 years on","volume":"15","author":"Maki","year":"2012","journal-title":"Climacteric"},{"issue":"2, suppl 1","key":"10.1016\/j.mayocp.2016.04.009_bib85","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","article-title":"Side effects of androgen deprivation therapy: monitoring and minimizing toxicity","volume":"61","author":"Higano","year":"2003","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib86","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(09)70338-9","article-title":"Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial","volume":"11","author":"Irani","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib87","first-page":"642","article-title":"Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer","volume":"174","author":"Langenstroer","year":"2005","journal-title":"J\u00a0Urol"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib88","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1586\/eem.11.20","article-title":"Estrogen action and prostate cancer","volume":"6","author":"Nelles","year":"2011","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib89","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1470-2045(13)70025-1","article-title":"Cardiovascular outcomes in patients with locally advanced and metastatic prostate cancer treated with luteinising-hormone-releasing-hormone agonists or transdermal oestrogen: the randomised, phase 2 MRC PATCH trial (PR09)","volume":"14","author":"Langley","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib90","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1200\/JCO.1999.17.3.1086a","article-title":"Prostate-specific antigen decline after withdrawal of low-dose megestrol acetate","volume":"17","author":"Burch","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib91","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00007611-199904000-00013","article-title":"Progressive prostate cancer associated with use of megestrol acetate administered for control of hot flashes","volume":"92","author":"Sartor","year":"1999","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib92","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrurol.2014.345","article-title":"Switching and withdrawing hormonal agents for castration-resistant prostate cancer","volume":"12","author":"Lorente","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.mayocp.2016.04.009_bib93","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7819-9-101","article-title":"Clinical relevance of \u201cwithdrawal therapy\u201d as a form of hormonal manipulation for breast cancer","volume":"9","author":"Agrawal","year":"2011","journal-title":"World J Surg Oncol"},{"issue":"8962","key":"10.1016\/j.mayocp.2016.04.009_bib94","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/S0140-6736(95)92632-1","article-title":"Breast cancer response to hormone replacement therapy withdrawal","volume":"345","author":"Powles","year":"1995","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib95","first-page":"128","article-title":"Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB","volume":"8","author":"Moraska","year":"2010","journal-title":"J\u00a0Support Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib96","first-page":"634","article-title":"Transdermal clonidine for ameliorating post-orchiectomy hot flashes","volume":"151","author":"Loprinzi","year":"1994","journal-title":"J\u00a0Urol"},{"issue":"10","key":"10.1016\/j.mayocp.2016.04.009_bib97","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.4065\/79.10.1247","article-title":"Pilot evaluation of paroxetine for treating hot flashes in men","volume":"79","author":"Loprinzi","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib98","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.pcan.4500891","article-title":"Pilot evaluation of selective serotonin reuptake inhibitor antidepressants in hot flash patients under androgen-deprivation therapy for prostate cancer","volume":"9","author":"Naoe","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib99","first-page":"98","article-title":"Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer","volume":"162","author":"Quella","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1099-1611(199803\/04)7:2<129::AID-PON294>3.0.CO;2-T","article-title":"Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancer","volume":"7","author":"Roth","year":"1998","journal-title":"Psychooncology"},{"issue":"32","key":"10.1016\/j.mayocp.2016.04.009_bib101","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1200\/JCO.2012.48.1432","article-title":"Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer","volume":"31","author":"Vitolins","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib102","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/GME.0b013e3182a122c2","article-title":"Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society","volume":"20","year":"2013","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib103","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4065\/mcp.2009.0413","article-title":"Vulvovaginal atrophy","volume":"85","author":"Mac Bride","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.mayocp.2016.04.009_bib104","first-page":"1790","article-title":"Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey","volume":"10","author":"Kingsberg","year":"2013","journal-title":"J\u00a0Sex Med"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/GME.0b013e318295236f","article-title":"Clarifying Vaginal Atrophy's Impact on Sex and Relationships (CLOSER) survey: emotional and physical impact of vaginal discomfort on North American postmenopausal women and their partners","volume":"21","author":"Simon","year":"2014","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib106","first-page":"1575","article-title":"Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial","volume":"10","author":"Chen","year":"2013","journal-title":"J\u00a0Sex Med"},{"issue":"1","key":"10.1016\/j.mayocp.2016.04.009_bib107","first-page":"65","article-title":"The effect of hyaluronic acid (Cicatridine) on healing and regeneration of the uterine cervix and vagina and vulvar dystrophy therapy","volume":"32","author":"Markowska","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib108","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"issue":"suppl","key":"10.1016\/j.mayocp.2016.04.009_bib109","article-title":"The effects of vaginal estrogens (VE) on serum estradiol levels in postmenopausal breast cancer survivors receiving an aromatase inhibitor (AI) or a selective estrogen receptor modulator (SERM)","volume":"69","author":"Wills","year":"2009","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib110","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1200\/JOP.2011.000352","article-title":"Effects of vaginal estrogens on serum estradiol levels in postmenopausal breast cancer survivors and women at risk of breast cancer taking an aromatase inhibitor or a selective estrogen receptor modulator","volume":"8","author":"Wills","year":"2012","journal-title":"J\u00a0Oncol Pract"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib111","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/13697137.2014.991301","article-title":"Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer","volume":"18","author":"Buchholz","year":"2015","journal-title":"Climacteric"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib112","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/GME.0000000000000428","article-title":"Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)","volume":"22","author":"Archer","year":"2015","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib113","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3109\/13697137.2014.992012","article-title":"Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy","volume":"18","author":"Bouchard","year":"2015","journal-title":"Climacteric"},{"issue":"5s, suppl","key":"10.1016\/j.mayocp.2016.04.009_bib114","article-title":"Impact of vaginal dehydroepiandrosterone (DHEA) on vaginal symptoms in cancer survivors trial N10C1 (Alliance)","volume":"32","author":"Barton","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib115","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/gme.0b013e3181c1ac01","article-title":"Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study","volume":"17","author":"Bachmann","year":"2010","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib116","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/gme.0b013e318279ba64","article-title":"Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy","volume":"20","author":"Portman","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/j.mayocp.2016.04.009_bib117","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jsbmb.2013.12.011","article-title":"Use of SERMs for treatment in postmenopausal women","volume":"142","author":"Pinkerton","year":"2014","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib118","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.maturitas.2012.12.002","article-title":"Ospemifene, vulvovaginal atrophy, and breast cancer","volume":"74","author":"Wurz","year":"2013","journal-title":"Maturitas"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib119","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2014.975197","article-title":"Sexual function after fractional microablative CO(2) laser in women with vulvovaginal atrophy","volume":"18","author":"Salvatore","year":"2015","journal-title":"Climacteric"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/13697137.2014.899347","article-title":"A\u00a012-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study","volume":"17","author":"Salvatore","year":"2014","journal-title":"Climacteric"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib121","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2053369115577328","article-title":"Intravaginally applied oxytocin improves post-menopausal vaginal atrophy","volume":"21","author":"Al-Saqi","year":"2015","journal-title":"Post Reprod Health"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib122","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/(SICI)1096-9896(200003)190:4<470::AID-PATH550>3.0.CO;2-G","article-title":"Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance","volume":"190","author":"Cassoni","year":"2000","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.mayocp.2016.04.009_bib123","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/BF00197549","article-title":"Oxytocin inhibits proliferation of human breast cancer cell lines","volume":"425","author":"Cassoni","year":"1994","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib124","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.20017","article-title":"Oxytocin inhibits the progression of human ovarian carcinoma cells in\u00a0vitro and in\u00a0vivo","volume":"109","author":"Morita","year":"2004","journal-title":"Int J Cancer"},{"issue":"30","key":"10.1016\/j.mayocp.2016.04.009_bib125","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2014.60.7366","article-title":"A\u00a0practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial","volume":"33","author":"Goetsch","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2016.04.009_bib126","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/pon.1947","article-title":"Patient experiences with communication about sex during and after treatment for cancer","volume":"21","author":"Flynn","year":"2012","journal-title":"Psychooncology"},{"issue":"9","key":"10.1016\/j.mayocp.2016.04.009_bib127","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/pon.3736","article-title":"Sexual health communication between cancer survivors and providers: how frequently does it occur and which providers are preferred?","volume":"24","author":"Sporn","year":"2015","journal-title":"Psychooncology"},{"issue":"3","key":"10.1016\/j.mayocp.2016.04.009_bib128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1019953027596","article-title":"Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy","volume":"75","author":"Broeckel","year":"2002","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib129","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01806673","article-title":"Breast cancer survivors: psychosocial concerns and quality of life","volume":"38","author":"Ganz","year":"1996","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.1998.16.2.501","article-title":"Life after breast cancer: understanding women's health-related quality of life and sexual functioning","volume":"16","author":"Ganz","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2016.04.009_bib131","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.mayocp.2016.04.009_bib132","first-page":"281","article-title":"Sexual dysfunction in women: a practical approach","volume":"92","author":"Faubion","year":"2015","journal-title":"Am Fam Physician"},{"issue":"2","key":"10.1016\/j.mayocp.2016.04.009_bib133","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.mayocp.2011.09.004","article-title":"Recognition and management of nonrelaxing pelvic floor dysfunction","volume":"87","author":"Faubion","year":"2012","journal-title":"Mayo Clin Proc"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619616301173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619616301173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T15:41:53Z","timestamp":1656949313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619616301173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":133,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0025619616301173"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2016.04.009","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Hormone Deprivation Symptoms After Cancer","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2016.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}